Cyclophosphamide induces mRNA, protein and enzyme activity of cytochrome P450 in rat

被引:14
|
作者
Xie, H
Afsharian, P
Terelius, Y
Mirghani, RA
Yasar, Ü
Hagbjörk, AL
Lundgren, S
Hu, Y
Rane, A
Hassan, M [1 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst,Novum, KFC,Dept Med,Div Hematol, Hematol Lab, S-14186 Huddinge, Sweden
[2] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, S-14186 Huddinge, Sweden
[3] AstraZeneca R&D Sodertalje, Dept Res DMPK, Sodertalje, Sweden
关键词
cyclophosphamide; cytochrome P450; induction; pharmacogenetic; CYP2B; CYB2C; CYP3A;
D O I
10.1080/00498250500057369
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of cyclophosphamide (CPA) on CYP enzymes in vivo and its auto induction in rat were investigated in Wistar/Fu male rats at a single dose ( 40 or 200 mg kg(-1)) or as repeated dose of 200 mg kg(-1) CPA. After a single dose of CPA, mRNAs of CYPs 2B1, 2B2, 3A2, 2C11 were significantly induced up to 220-, 6.7-, 5.0- and 5.8-fold at the low dose CPA, and 4800-, 52-, 22- and 2.5-fold at the high dose. CYP2B1/2 and CYP3A proteins were increased by 4- and 2-fold ( low dose) and by 28- and 1.7-fold ( high dose). CYP2C11 protein levels were not altered. Microsomal activities of CYP2B, CYP3A and 2C11 were increased by 2-, 1.8- and 1.3-fold at low dose CPA, and 3.2-, 1.7- and 1.6-fold at high dose. A significant (p< 0.05) decrease in CPA concentration and a significant ( p < 0.05) increase in 4-OH-CPA levels were observed with repeated administration of CPA. Acute induction effect on CYP2B1, 2B2, 2C11 and 3A2 and a substantial up regulation of CYP2B1 mRNA were observed after a single dose of CPA, auto induction was observed by repeated administration.
引用
收藏
页码:239 / 251
页数:13
相关论文
共 50 条
  • [41] The crystal structure of the cytochrome P450 enzyme TxtE
    Yu, F.
    Li, M.
    Xu, C.
    Wang, Z.
    Zhou, H.
    Yang, M.
    Chen, Y.
    He, J.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2014, 70 : C1683 - C1683
  • [42] Cytochrome P450: Enzyme regulation and toxicological significance
    Ueng, TH
    Kang, JJ
    Chao, IC
    Chen, YC
    JOURNAL OF FOOD AND DRUG ANALYSIS, 1996, 4 (01) : 13 - 23
  • [43] Recent progress in cytochrome P450 enzyme electrochemistry
    Fleming, Barry D.
    Johnson, Daniel L.
    Bond, Alan M.
    Martin, Lisandra L.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (04) : 581 - 589
  • [44] Effects of obesity on the cytochrome P450 enzyme system
    Kotlyar, M
    Carson, SW
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1999, 37 (01) : 8 - 19
  • [45] Measurement of cytochrome P450 and NADPH–cytochrome P450 reductase
    F Peter Guengerich
    Martha V Martin
    Christal D Sohl
    Qian Cheng
    Nature Protocols, 2009, 4 : 1245 - 1251
  • [46] Protein engineering of cytochrome P450(cam)
    Wong, LL
    Westlake, CG
    Nickerson, DP
    METAL SITES IN PROTEINS AND MODELS: IRON CENTRES, 1997, 88 : 175 - 207
  • [47] Effect of claudin on cytochrome P450 activity
    Shimizu, Yoshimi
    Kondoh, Masuo
    Watari, Akihiro
    Fukasawa, Masayoshi
    Yagi, Kiyohito
    FASEB JOURNAL, 2013, 27
  • [48] Effect of Cellgevity® Supplement on Selected Rat Liver Cytochrome P450 Enzyme Activity and Pharmacokinetic Parameters of Carbamazepine
    Amponsah, Seth Kwabena
    N'guessan, Benoit Banga
    Akandawen, Martin
    Aning, Abigail
    Agboli, Sedem Yawa
    Danso, Eunice Ampem
    Opuni, Kwabena Frimpong-Manso
    Asiedu-Gyekye, Isaac Julius
    Appiah-Opong, Regina
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [49] Thiomers: Inhibition of cytochrome P450 activity
    Iqbal, Javed
    Sakloetsakun, Duangkamon
    Bernkop-Schnuerch, Andreas
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 78 (03) : 361 - 365
  • [50] Effect of methamphetamine on cytochrome P450 activity
    Dostalek, M.
    Jurica, J.
    Pistovcakova, J.
    Hanesova, M.
    Tomandl, J.
    Linhart, I.
    Sulcova, A.
    XENOBIOTICA, 2007, 37 (12) : 1355 - 1366